Movetis Proves Gutsy with IPO: €85M for Resolor, GI Pipeline
No Abstract
Rumors of another European initial public offering in the works - this one by Brussels, Belgium-based Movetis - proved true, and the cash raised fell nicely within the range of speculators: €85 million (US$126 million), through the sale of about 6.9 million shares at €12.25 each.
About 1 million shares as an overallotment, equivalent to €12.75 million, are allocated, and if that option is exercised in full by underwriters, the money garnered by the IPO will increase to €97.75 million.
To continue reading subscribe now to BioWorld Today
Learn More about BioWorld Today
Already a subscriber? Sign In or Buy now to activate your subscription
BioWorld | 3525 Piedmont Road
Building 6, Suite 400 | Atlanta, Georgia 30305, USA
Building 6, Suite 400 | Atlanta, Georgia 30305, USA
Part of Thompson Media Group LLC
Free Ezine
Sign up for Perspectives FREE e-mail newsletter.
Customer Service: In the U.S. and Canada: 1-800-477-6307
Outside the U.S.: 1-404-262-5423
customerservice@bioworld.com
Hours: Monday - Thursday, 8:30 am - 6:00 pm EST
Friday, 8:30am - 4:30 pm EST
Outside the U.S.: 1-404-262-5423
customerservice@bioworld.com
Hours: Monday - Thursday, 8:30 am - 6:00 pm EST
Friday, 8:30am - 4:30 pm EST
Copyright @ 2013 AHC Media. Reproduction, reposting content is strictly prohibited.